What is it about?

Campylobacter is one of the most frequent causes of bacterial diarrhoea, usually picked up from undercooked poultry. In elderly or immunocompromised people it can occasionally invade the bloodstream (bacteremia), but how serious this is has been unclear. We pooled 25 studies published between 1978 and 2024, including 2,480 patients with Campylobacter bacteremia. C. jejuni caused 60% of cases, followed by C. coli and C. fetus. Overall, about 5 in 100 patients died. Death was more likely with C. fetus, in immunocompromised patients and in those with chronic liver disease. About 9% developed infections spreading to other sites, such as blood vessels, 3% relapsed and 2% developed endocarditis.

Featured Image

Why is it important?

Campylobacter in the blood is often considered a benign, self-limiting event. Our meta-analysis shows it carries a real risk of death and complications, especially with C. fetus and in fragile patients. These findings support careful evaluation, appropriate antibiotic treatment and a search for endovascular foci in high-risk patients, and they call for prospective studies to define the best management.

Perspectives

Campylobacter has been a research interest of our group in Trieste for years, from Italian epidemiology to bloodstream infections. This international work, led by Verena Zerbato with colleagues from Italy, Romania, Iran and the USA, gives clinicians the first pooled estimates of outcomes for an infection we see regularly but know surprisingly little about.

Professor Stefano Di Bella
Universita degli Studi di Trieste

Read the Original

This page is a summary of: Clinical Outcomes of Campylobacter Bacteremia: A Systematic Review with Meta-Analysis, Pathogens, June 2026, MDPI AG,
DOI: 10.3390/pathogens15070686.
You can read the full text:

Read

Contributors

The following have contributed to this page